Hayley E. Tyrer
Preston, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Transcript Analysis Reveals a Hypoxic Inflammatory Environment in Human Chronic Otitis Media With Effusion.
Journal: Frontiers in genetics
Published: July 21, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis.
Journal: Journal of medicinal chemistry
Published: February 08, 2019
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.
Journal: Science translational medicine
Published: May 17, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Journal: Scientific reports
Published: January 20, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
Journal: Scientific reports
Published: January 09, 2018
Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 29, 2017
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.
Journal: Scientific reports
Published: October 26, 2017
A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.
Journal: PLoS genetics
Published: May 27, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Journal: Scientific reports
Published: October 04, 2016
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
Journal: Scientific reports
Published: January 05, 2016
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis.
Journal: Parasites & vectors
Published: August 19, 2014
What have we learned from murine models of otitis media?
Journal: Current allergy and asthma reports
Published: June 19, 2013
Last Updated: 09/26/2026